Kymera Therapeutics (KYMR) Receivables - Net (2020 - 2025)

Kymera Therapeutics (KYMR) has 4 years of Receivables - Net data on file, last reported at $40.0 million in Q2 2025.

• Receivables - Net for Q2 2025 came in at $40.0 million, changed N/A year-over-year; the trailing twelve-month figure through Jun 2025 was $40.0 million (changed N/A YoY), and the FY2023 annual result was $15.0 million, changed N/A from the prior year.
• Receivables - Net rose to $40.0 million in Q2 2025 per KYMR's latest filing, from $15.0 million in the prior quarter.
• Over five years, Receivables - Net peaked at $40.0 million in Q2 2025 and troughed at $900000.0 in Q1 2021.
• A 3-year average of $18.6 million and a median of $15.0 million in 2023 frame the typical range for Receivables - Net.